What China’s expanded funding for HIV/Aids in Africa means as US cuts health aid

China is increasing its involvement in the global fight against HIV/AIDS in Africa through funding initiatives like the Health Silk Road. As Western aid organizations like the US Agency for International Development and the President's Emergency Plan for AIDS Relief (PEPFAR) reduce their support, China's Global Development and South-South Cooperation Fund is stepping in to provide financial backing for HIV prevention projects in countries such as Lesotho, South Africa, Uganda, and Zimbabwe.

South Africa, which has over eight million people living with HIV, recently received a US$3.49 million grant from China for prevention programs targeting young people and harm-reduction services for people who inject drugs. Additionally, China is supporting projects aimed at ending mother-to-child transmission of HIV, syphilis, and hepatitis B in Uganda.

UNAIDS Executive Director Winnie Byanyima welcomed China's commitment to multilateralism and the potential for further project funding proposals. This funding aligns with China's broader health diplomacy efforts, which have already seen China fund Ebola and malaria programs across the continent. While China's financial contribution to HIV/AIDS remains modest compared to traditional donors like the US and the Global Fund, it is becoming increasingly important due to potential reductions in traditional donor funding.

China's role is believed to be more capacity-oriented, focusing on building pharmaceutical manufacturing, vaccine production, CDC laboratories, hospital infrastructure, and digital health systems in Africa.